Alveolar metabolism of natural vs. synthetic surfactants in preterm newborn rabbits

J Appl Physiol (1985). 2001 Jan;90(1):198-204. doi: 10.1152/jappl.2001.90.1.198.

Abstract

We compared the recoveries of four surfactant preparations: two natural [term fetal rabbit surfactant (FRS) and adult rabbit surfactant (ARS)] and two commercially available preparations [apoprotein-based Survanta (S) and synthetic Exosurf (E)] from 27-day gestation rabbit pups treated at birth and ventilated up to 120 min. At 5, 60, and 120 min, we measured the recovery of the heavy-aggregate, metabolically active form (H) and the light-aggregate, nonsurface active metabolic breakdown form (L) of alveolar surfactant and determined the phospholipid content and composition of the intracellularly stored lamellar body (LB) pool. Pups treated with FRS had <15% loss of H by 2 h. ARS-treated pups had a >50% loss of H by 1 h, and E- and S-treated pups had approximately 50% loss by 5 min, with a slower rate of continuing loss of up to 80% by 2 h. The major losses of H phospholipid were not explained by the L-form recovery. LB phospholipid significantly increased only in the E-treated pups and only at 2 h. FRS provides a biologically active form (H) of surfactant that appeared to remain in the airway for a significantly longer time than the other surfactant preparations. The unique properties of FRS merit further study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn / metabolism*
  • Biological Products*
  • Drug Combinations
  • Fatty Alcohols / metabolism*
  • Fetus / metabolism
  • Gestational Age
  • Phospholipids / metabolism
  • Phosphorylcholine*
  • Polyethylene Glycols / metabolism*
  • Pulmonary Alveoli / metabolism*
  • Pulmonary Surfactants / metabolism*
  • Rabbits
  • Therapeutic Irrigation
  • Time Factors

Substances

  • Biological Products
  • Drug Combinations
  • Fatty Alcohols
  • Phospholipids
  • Pulmonary Surfactants
  • Phosphorylcholine
  • Polyethylene Glycols
  • dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination
  • beractant